Top Markets
Coin of the day
Enimmune corporation Enimmune corporation

Enimmune corporation

6564
Rang in aandelen #26784
Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused... Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused on the research, development, and commercialization of pharmaceutical products. Among its key offerings is Tuberculin PPD RT23 SSI, an approved diagnostic agent utilized in tuberculin tests to ascertain the presence of tuberculosis infection in patients. Beyond its existing products, Enimmune is heavily invested in developing vaccines aimed at combating a diverse array of infectious diseases. These include, but are not limited to, vaccines for enterovirus, pneumonia, norovirus, dengue fever, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Established in 2014, the company maintains its headquarters in Taichung City, Taiwan.
Aandeelprijs
$0.52468396
Marktkapitalisatie
$37.85M
Verandering (1 dag)
1.23%
Verandering (1 jaar)
-4.53%
Land
TW
Handel Enimmune corporation (6564)

Categorie

Koersgeschiedenis voor Enimmune corporation (6564)
Hoogste slotkoers: $0.53 op 2026-08-01

Laagste slotkoers: $0.89 op 2018-09-01
Koersgeschiedenis van Enimmune corporation van 2018 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -7.73%
2025 -21.37%
2024 -30.67%
2023 -42.89%
2022 47.58%
2021 -3.50%
2020 86.97%
2019 -4.98%
2018 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$541.84 37.40%
US
$1.03K 55.89%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$129.21 380.51%
US